Y
ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Psychiatry · Lancet Psychiatry · 2026-10-01

In 130 outpatients with schizophrenia or schizoaffective disorder in Berlin, modified psychodynamic psychotherapy plus usual care improved psychosocial functioning (Mini-ICF-APP) vs usual care alone: difference −3·45 at 24 months, −4·07 at 36 months.

RCTn = 130
Montag et al. The efficacy of modified psychodynamic psychotherapy for patients with schizophrenia-spectrum disorders in Germany: a prospective, single-centre, assessor-blinded, parallel-group, randomised controlled trial
Psychiatry · Lancet Psychiatry · 2026-09-30

Individual participant data meta-analysis of 18 fixed-dose trials (7062 adults with acute schizophrenia): no sex difference in antipsychotic effect on overall symptoms (DoSMD 0·04, 95% CI −0·09 to 0·18). Prolactin rise was greater in females; dropout fell more in females.

Meta-analysisn = 7,062
Furukawa et al. Sex differences in the efficacy, acceptability, and tolerability of antipsychotics in people with acute schizophrenia: individual participant data pairwise, dose-response, and network meta-analyses
Psychiatry · Lancet Psychiatry · 2026-08-26

In a cluster-randomised trial of 494 adults in mental health crisis in England, Open Dialogue did not significantly lengthen time to first relapse versus usual care (HR 0·95, 95% CI 0·67–1·32); secondary outcomes, including admissions and self-rated recovery, favoured it.

RCTn = 494
Pilling et al. Open Dialogue versus treatment as usual for adults presenting in crisis to mental health services in England (the ODDESSI Trial): a multisite cluster-randomised trial
Psychiatry · Lancet Psychiatry · 2026-08-24

Meta-analysis of 417 relapsing patients in five paliperidone withdrawal trials: rapid relapse was no more common on placebo than on continued drug (injectable 20% vs 11%, p=0.12; oral 27% vs 26%) and was linked to higher baseline symptom severity.

Meta-analysisn = 417
Louie et al. Relapse trajectories and antipsychotic discontinuation in schizophrenia from individual participant data of five trials from the Yale Open Data Access database: a meta-analysis

Sign in to react

Enter your email and we send a one-time link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.